Physician-researchers with City of Hope have developed a way to add features to T cells to help them overcome mechanisms of ...

A new paper from MUSC Hollings Cancer Center researchers is helping to reveal the "rules" for engineering chimeric antigen ...

The advent of cellular therapies, such as chimeric antigen receptor T-cell therapy, has revolutionized the field of ...

T-cell therapy is a type of cancer immunotherapy where patients' T-cells are collected and genetically modified to produce ...

The director of solid tumor therapy at Stanford Medicine describes how cellular therapies are transforming cancer care.

Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being ...

Various forms of blood cancer exist—all of which are grouped together under the term leukemia. One common form of leukemia is ...

Through interviews and articles infused with expert insight, progress against this cancer that develops in the bone marrow ...

Chimeric antigen receptor T-cell or CAR T therapy shows promise for patients with refractory or relapsing B-cell lymphomas.

Immunotherapy has significantly advanced cancer treatment, particularly through T cell-driven strategies. Among these, adoptive cell therapies like Chimeric ...

A Philadelphia cell therapy developer has initiated its first human testing of a potential cancer treatment. Vittoria ...